MONTREAL, QUEBEC -- (MARKET WIRE) -- April 23, 2007 -- IBEX Technologies Inc. (TSX: IBT), announced today that Paul Baehr, President and CEO, will give a corporate review and provide an update on its transition to becoming a specialty pharmaceutical company at the BioFinance 2007 conference on Wednesday, April 25th, 2007, at 10:30 a.m. EDT, in room Trinity II of the Toronto Marriott Eaton Centre. A copy of the presentation will be available at www.ibex.ca following the presentation.
